Author: Dorron Blumberg

image_pdfimage_print

M2GEN Announces New Collaboration with Merck to Advance Cancer Therapies

Merck Secures 5-year Access to Data Supporting Oncology Research
 
March 17, 2021 – M2GEN, a leading oncology-focused data and informatics company, announced today a significant new five-year agreement with Merck, known as MSD outside the United States and Canada. Under the terms of the agreement, M2GEN will provide valuable patient-consented, de-identified, linked clinical and genomic data in support of Merck’s oncology efforts.
 

Read More

Palmetto General Hospital Names Norma Montlaban a Tenet Hero

Special honor is part of Tenet Healthcare’s annual recognition program
 
March 17th,  2021 – Palmetto General Hospital announced today that Norma Montlaban, Infection Control Preventionist, has been honored by Tenet Healthcare as part of its annual recognition program. Norma has been named a “Tenet Hero” for her incredible contributions in 2020.
 
 

Read More